Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Introgen obtains exclusive worldwide license for tumor suppressor genes

Oct. 17, 2001

ODAC meeting rescheduled for early December

Oct. 17, 2001

Inhibitors of MMPs designed at Advanced Syntech

Oct. 16, 2001

Japanese pharmaceutical company identifies peptides inhibiting PSA activity

Oct. 16, 2001

Antitumor antibiotics discovered at MCRF in Streptomyces

Oct. 15, 2001

Inhibitors of CDKs useful as anticancer agents

Oct. 15, 2001

Peregrine's Cotara receives FDA fast track review status

Oct. 15, 2001

MGI Pharma expands phase II irofulven clinical trial in ovarian cancer

Oct. 15, 2001

Matrix to initiate new study of tezacitabine in AML

Oct. 15, 2001

Cell Pathways encouraged by rapid progress made in clinical studies of CP-461 for CLL

Oct. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...